Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands.
Hum Mol Genet. 2018 Jun 1;27(11):1879-1891. doi: 10.1093/hmg/ddy089.
The MIR137 locus is a replicated genetic risk factor for schizophrenia. The risk-associated allele is reported to increase miR-137 expression and miR-137 overexpression alters synaptic transmission in mouse hippocampus. We investigated the cellular mechanisms underlying these observed effects in mouse hippocampal neurons in culture. First, we correlated the risk allele to expression of the genes in the MIR137 locus in human postmortem brain. Some evidence for increased MIR137HG expression was observed, especially in hippocampus of the disease-associated genotype. Second, in mouse hippocampal neurons, we confirmed previously observed changes in synaptic transmission upon miR-137 overexpression. Evoked synaptic transmission and spontaneous release were 50% reduced. We identified defects in release probability as the underlying cause. In contrast to previous observations, no evidence was obtained for selective synaptic vesicle docking defects. Instead, ultrastructural morphometry revealed multiple effects of miR-137 overexpression on docking, active zone length and total vesicle number. Moreover, proteomic analyses of neuronal protein showed that expression of Syt1 and Cplx1, previously reported as downregulated upon miR-137 overexpression, was unaltered. Immunocytochemistry of synapses overexpressing miR-137 showed normal Synaptotagmin1 and Complexin1 protein levels. Instead, our proteomic analyses revealed altered expression of genes involved in synaptogenesis. Concomitantly, synaptogenesis assays revealed 31% reduction in synapse formation. Taken together, these data show that miR-137 regulates synaptic function by regulating synaptogenesis, synaptic ultrastructure and synapse function. These effects are plausible contributors to the increased schizophrenia risk associated with miR-137 overexpression.
MIR137 基因座是精神分裂症的复制遗传风险因素。报道称,风险相关等位基因可增加 miR-137 的表达,miR-137 的过表达可改变小鼠海马体的突触传递。我们在体外培养的小鼠海马神经元中研究了这些观察到的效应的细胞机制。首先,我们将风险等位基因与人类死后大脑中 MIR137 基因座的基因表达相关联。观察到 MIR137HG 表达增加的一些证据,尤其是在疾病相关基因型的海马体中。其次,在小鼠海马神经元中,我们证实了以前观察到的 miR-137 过表达对突触传递的影响。诱发的突触传递和自发释放减少了 50%。我们确定释放概率的缺陷是潜在的原因。与之前的观察结果相反,没有证据表明存在选择性突触囊泡对接缺陷。相反,超微结构形态计量学显示 miR-137 过表达对对接、活性区长度和总囊泡数量有多种影响。此外,神经元蛋白的蛋白质组学分析表明,先前报道的 Syt1 和 Cplx1 的表达在 miR-137 过表达时下调,未发生改变。过表达 miR-137 的突触的免疫细胞化学显示突触结合蛋白 1 和复杂素 1 蛋白水平正常。相反,我们的蛋白质组学分析显示参与突触发生的基因表达发生改变。同时,突触发生测定显示突触形成减少 31%。综上所述,这些数据表明 miR-137 通过调节突触发生、突触超微结构和突触功能来调节突触功能。这些效应可能是 miR-137 过表达与精神分裂症风险增加相关的原因。